Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0RB9

Stallergenes Greer (0RB9)

Stallergenes Greer Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RB9
DateTimeSourceHeadlineSymbolCompany
05/16/20196:00AMUK RegulatoryStallergenes Greer plc Recommended Cash Acquisition of Stallergenes Greer plc by Ares Life Sciences I S.à r.l.LSE:0RB9Stallergenes Greer Plc
12/12/201810:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Confirms Appointments to the Board of DirectorsLSE:0RB9Stallergenes Greer Plc
11/20/20181:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet ...LSE:0RB9Stallergenes Greer Plc
11/14/20181:00AMUK RegulatoryStallergenes Greer plc Regulatory ApprovalLSE:0RB9Stallergenes Greer Plc
08/30/20181:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 20...LSE:0RB9Stallergenes Greer Plc
08/16/20181:00AMUK RegulatoryStallergenes Greer plc Notice of ResultsLSE:0RB9Stallergenes Greer Plc
06/07/201811:30AMUK RegulatoryStallergenes Greer plc Result of AGMLSE:0RB9Stallergenes Greer Plc
06/07/20181:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Provides Business Update and Refines Its 2018 Financial OutlookLSE:0RB9Stallergenes Greer Plc
05/29/20186:30AMUK RegulatoryStallergenes Greer plc Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Alle...LSE:0RB9Stallergenes Greer Plc
04/23/20181:00AMUK RegulatoryStallergenes Greer plc Notice of AGMLSE:0RB9Stallergenes Greer Plc
04/16/20181:00AMUK RegulatoryStallergenes Greer plc Annual Financial ReportLSE:0RB9Stallergenes Greer Plc
03/22/20182:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Reports Solid Growth and Continued Recovery in 2017, Delivering on Full Year GuidanceLSE:0RB9Stallergenes Greer Plc
03/15/201812:31PMUK RegulatoryStallergenes Greer plc Stallergenes Greer to Report Full Year Financial Results on 22 March 2018LSE:0RB9Stallergenes Greer Plc
02/16/20181:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Announces Approval in Japan of Pediatric Use for ACTAIR®, Sublingual Immunotherapy...LSE:0RB9Stallergenes Greer Plc
01/26/20181:00AMUK RegulatoryStallergenes Greer plc Stallergenes Greer Comments on Share Price MovementLSE:0RB9Stallergenes Greer Plc
 Showing the most relevant articles for your search:LSE:0RB9